Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of r… Read more
Atrys Health SL - Asset Resilience Ratio
Atrys Health SL (ATRY) has an Asset Resilience Ratio of 1.20% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Atrys Health SL's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Atrys Health SL's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €6.97 Million | 1.2% |
| Total Liquid Assets | €6.97 Million | 1.20% |
Asset Resilience Insights
- Limited Liquidity: Atrys Health SL maintains only 1.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Atrys Health SL Industry Peers by Asset Resilience Ratio
Compare Atrys Health SL's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Atrys Health SL (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Atrys Health SL.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.53% | €8.93 Million | €584.19 Million | +1.44pp |
| 2023-12-31 | 0.09% | €554.00K | €629.00 Million | -0.16pp |
| 2022-12-31 | 0.25% | €1.77 Million | €705.28 Million | -0.91pp |
| 2021-12-31 | 1.16% | €6.57 Million | €565.63 Million | -8.86pp |
| 2020-12-31 | 10.02% | €17.61 Million | €175.78 Million | +0.07pp |
| 2019-12-31 | 9.95% | €8.76 Million | €88.04 Million | -8.51pp |
| 2018-12-31 | 18.46% | €9.91 Million | €53.69 Million | +18.11pp |
| 2017-12-31 | 0.35% | €141.87K | €40.20 Million | -0.23pp |
| 2016-12-31 | 0.59% | €179.05K | €30.57 Million | +0.39pp |
| 2015-12-31 | 0.19% | €50.21K | €26.10 Million | -0.06pp |
| 2014-12-31 | 0.26% | €50.21K | €19.53 Million | -1.37pp |
| 2013-12-31 | 1.63% | €307.64K | €18.87 Million | -13.65pp |
| 2012-12-31 | 15.28% | €2.80 Million | €18.29 Million | -- |